This event has ended

Prostate Cancer: Progress and Promise, Part V

Society for Translational Oncology

Thursday, January 30, 2014 from 7:00 PM to 10:00 PM (PST)

San Francisco, CA

Prostate Cancer: Progress and Promise, Part V

Registration Information

Type End     Quantity
General Admission   more info Ended Free  

Who's Going

Loading your connections...

Share Prostate Cancer: Progress and Promise, Part V

Event Details

STO joint logo

Plan to attend this CME Ancillary Meeting at the
2014 Genitourinary Cancers Symposium 

 Not an official event of the 2014 GU Cancers Symposium. Not sponsored or endorsed by any of the cosponsoring organizations of the 2014 GU Cancers Symposium.

Thursday, January 30, 2014
San Francisco Marriott Marquis
The Club Room, Second Level

Registration desk opens at 7:15pm

Light refreshments and snacks will be available. 

CME Activity begins at 7:30pm and ends at 9:45pm

Event summary:

Over the last three years we have seen major improvement in prognosis for prostate cancer patients. Trials showing improved survival for men with previously untreatable disease have been conducted in improved hormone therapy, chemotherapy, a new form of injectable radiotherapy, and a form of vaccination. While these are exciting developments, oncologists are still just beginning to introduce these therapies in clinical practice. One of the real challenges is how we will try to ensure the patients get optimal exposure to all of these drugs; for example, what order do we use them in? Do we use them in combination, and which do we give first? We are only just beginning to now tease those details apart in prostate cancer. This symposium will seek to answer your challenging questions and provide the most up to date information for clinical practice and give insight into novel therapies for the future. 

Symposium Chairman: Howard I. Scher, MD
Chief, Genitourinary Oncology Service and D. Wayne Calloway Chair in Urologic Oncology
Memorial Sloan-Kettering Cancer Center – New York, NY

 

Symposium Faculty:
Yu Chen, MD, PhD, Memorial Sloan-Kettering Cancer Center
Michael J. Morris, MD, Memorial Sloan-Kettering Cancer Center
Dana E. Rathkopf, MD, Memorial Sloan-Kettering Cancer Center

Symposium Moderator:
Professor John Fitzpatrick, Irish Cancer Society, Dublin, Ireland

Full faculty disclosure will be provided at the activity.

CME Provider and Supporter(s): This event is sponsored by the Society for Translational Oncology (STO) and the activity is supported by educational grants from Bayer Healthcare Pharmacueticals and Algeta US, Janssen Biotech, Inc., administered by Janssen Services, LLC, and Sanofi Oncology.

Any additional funding confirmed will be acknowledged at the live event.


Brought to you in partnership with 

TO logo


Have questions about Prostate Cancer: Progress and Promise, Part V? Contact Society for Translational Oncology

When & Where



San Francisco Marriott Marquis
780 Mission Street
San Francisco, CA 94103

Thursday, January 30, 2014 from 7:00 PM to 10:00 PM (PST)


  Add to my calendar

Organizer

Society for Translational Oncology

The mission of the Society for Translational Oncology (STO) is to speed the discovery and translation of important new treatments to global oncology practice.

STO is tax-exempt as a 501(c)(3) foundation (EIN: 20-3186261). 

  Contact the Organizer

Please log in or sign up

In order to purchase these tickets in installments, you'll need an Eventbrite account. Log in or sign up for a free account to continue.